Very little is, however, known regarding the cause, risk factor profile and clinical presentations of CAD in the black South African population. Steyn et al. (8) 
IntroductIon
While age-adjusted cardiovascular disease (CVD) death rates have declined in several developed countries, rates of CVD have increased disconcertingly in low-and middle-income countries. (1, 2) Coronary artery disease (CAD) specifically, has historically been remarkably rare in black South Africans, but studies are now showing an increase in prevalence especially in urban areas as a result of urbanisation. (3) (4) (5) Recognised risk factors that have been shown to be affected by urbanisation in the Transition and Health during Urbanisation in South Africans (THUSA) study include increases in hypertension, obesity, smoking habit and hyperfibrinogenaemia. (6) Changes in dietary intakes during urbanisation are considered to play a prominent role in the observed increase in risk factors. (7) With urbanisation, there is also an increase in socio-economic status, which is usually accompanied by an increase in other risk factors such as obesity and physical inactivity. Differences for instance occur in the prevalence of individual risk factors in black Africans compared to Caucasians such as hypertension and the lipid profile. The African population is known to be especially vulnerable to hypertension. (9) Kearney et al. (10) predicted that by 2025, 73.6 million men and 77.1 million women in sub-Saharan Africa will be hypertensive with urbanisation significantly contributing to this increased prevalence. (7) Black South Africans in general, on the other hand seem to have a favourable lipid profile with lower total cholesterol (TC) and higher high density lipoprotein cholesterol (HDL-C) levels than other ethnic groups in South Africa. (6) Black Africans with heart disease in the Heart of Soweto study also had lower cholesterol levels than other ethnicities. (5) Nethononda et al. (11) furthermore demonstrated that black South African CAD patients in their study, had cholesterol levels within the target range recommended by the adult treatment panel III (ATPIII) guidelines of the National Cholesterol Education Programme (NCEP).
Therefore, due to the increase in prevalence of CAD and to better understand the risk factor profile and pathophysiology thereof in black South Africans, we undertook a study to compare dietary intakes, physical activity level, socio-demographic background and biochemistry of angiographically defined black South African CAD patients with a control group from a similar socio-demographic background. We excluded the complex and confounding effects of diabetes and obesity by excluding diabetic patients and by matching CAD cases and controls for not only body mass index (BMI) but also for waist circumference and waist-hip ratio. 
Methods

Study population
MAterIALs And Methods
Demographic information, medical history, medication use and smoking status were obtained using questionnaires. A standardised and validated quantitative food frequency questionnaire, developed for the African population, together with a food portion photo book were used to determine dietary intakes. (12, 13) The nutrient intakes were analysed using the Medical Research Council's FoodFinder3 programme, which is based on the South African Food composition tables. (14) A standardised Physical Activity questionnaire (15) was used to calculate the Physical Activity Index.
Anthropometrical measurements consisted of height, weight and waist and hip circumference. Height and weight were used to calculate BMI.
Fasting blood samples were collected by a qualified nursing sister. were determined with an enzymatic colorimetric assay (NEFA, Roche Diagnostics GmbH, Mannheim, Germany). Insulin-mediated glucose disposal (M-value) was determined using the hyperinsulinaemic euglycaemic clamp technique and expressed as mg/kg/ min with a normal value being >5.0mg/kg/min and a value below this indicating insulin resistance. (17) Intima media thickness (IMT) was measured using B-mode ultrasound at the optimum angle of interrogation at the flow tip divider, the common carotid artery, external carotid artery and internal carotid artery at the bifurcation as described in detail by Holland et al. (18) stAtIstIcAL AnALysIs
Statistical analysis of data was done using the computer software package Statistica® version 8. Data is reported as median (25 -75 percentile) for non-parametric data or as mean (standard deviation) for parametric data. A p-value ≤0.05 was regarded as statistically significant. Independent T-tests were done on parametric data and for non-parametric data, the Mann Whitney U test was used when comparing the CAD patients to the control group.
Analysis of Co-Variance (ANCOVA) was used to determine differences between the CAD and control group after adjusting for possible confounding effects of age. Only variables that were found to be affected by age were adjusted for age. For the categorical variables, the Chi-square test was used. Spearman Rank order correlations were done to determine associations between risk factors and diet, physical activity and socio-demographic variables. Logistic regression was used to determine predictors for categorical variables such as LDL size and CAD.
resuLts
The clinical and biochemical characteristics of the study population are shown in Table 1 The metabolic syndrome as classified by the International Diabetes Federation (21) was present in 24 (60%) of the CAD patients compared to 8 (40%) of the controls. Although this is a marked difference, it was not found to be statistically different. Details pertaining to this high prevalence of metabolic syndrome in the CAD cases have been published elsewhere. (22) Using a logistic regression model that included the risk markers that differed between the CAD and control group, M-value, CRP
and LDL size were the main predictors of CAD.
The dietary intake, physical activity and socio-demographic information of the CAD patients and control group are reported in Table 2 and compared to the dietary guidelines for the prevention of CAD. The only nutrient that was found to be significantly different was the vitamin C intake (p=0.049) with CAD patients having a significantly lower intake than the control group. No differences were found in physical activity, income, and type of housing or education level between the groups. Both the CAD patients and the control group had a median Physical Activity
Index that fell in the moderately active category.
Both the CAD and the control group had a relatively high total energy intake (±10 000kJ) in comparison with their physical activity as can be seen by their increased median BMI (28 and 27.5kg/m 2 ). In general, the macronutrient distribution was within and the micronutrient intakes below the recommended ranges for prevention of CAD for both groups. Although total fat intake was within recommended ranges, the saturated fatty acid intake was above the recommended ranges and cholesterol intake was at the upper limit, while the intake of fibre, folate, selenium vitamin B6, vitamin C and E were all below the recommended intake, for both the CAD patients and the control group. The women in both the control and CAD group did not consume any alcohol.
dIscussIon
The purpose of this study was to help determine the risk factor profile and clinical presentations of CAD in black South Africans by excluding the confounding metabolic derangements that accompany the known risk factors, diabetes and obesity. The CAD patients had a higher prevalence of smoking, hypertension, small dense LDL and metabolic syndrome with specific emphasis on insulin resistance as well as increased LDL-C, TC, CRP and fasting glucose than the controls. These factors are all documented to be involved in atherosclerosis. (23) (24) (25) The decreased vitamin C intake together with increased smoking may confer additional risk through increased oxidative stress. (26) The main predictors of the development of CAD in this black South African population were small dense LDL and insulin resistance. While more CAD patients had metabolic syndrome (60%), compared to the control group (40%), it was insulin resistance per se that seemed to be the major distinguishing factor.
By excluding overt diabetes and matching for body fat distribution, it was possible to determine the independent contribution of insulin resistance amongst the many components of the metabolic syndrome. Insulin resistance, as well as the resultant hyperglycaemia, contribute to atherosclerosis through several mechanisms including modification of the lipid metabolism to produce a proatherogenic lipid profile, inflammatory signalling pathways such as NF-kB, MAP kinase and protein kinase C, direct effects on the vasculature, oxidative/mitochondrial stress and genomic stress. (27, 28) The lower leptin levels observed in the CAD group may furthermore facilitate the insulin resistance seen in this group. Leptin is considered to improve peripheral insulin sensitivity and modulates pancreatic ß-cell function. (29, 30) Small dense LDL confer atherogenic risk through increased transendothelial transport, increased susceptibility to oxidation, reduced LDL receptor affinity, increased binding to intimal proteoglycans
and increased formation of proaggregatory and vasoconstrictor mediators. (31) (32) (33) Some controversy still exists, however, regarding the independent predictive role of small dense LDL in CVD. The vast majority of both cross-sectional and prospective epidemiological studies have indicated a significant association between small, dense LDL and increased coronary heart disease risk. Only some studies, however, found it to be an independent predictor once adjusting for confounding variables such as increased plasma TG and decreased HDL-C levels (34, 35) that frequently accompany small, dense LDL. The CAD patients in this study did, however, not have decreased HDL-C nor increased TG, while 75% had small, dense LDL, suggesting that in the black South African population, LDL-size may independently confer additional risk.
From the results it seems that insulin resistance and to a lesser extent, smoking are strongly related to the presence of small dense LDL. Insulin resistance has also in the literature been shown to be strongly related to LDL size. (36, 37) It is suggested that in insulin resistance, non-esterified fatty acids released by adipocytes provide more triglycerides for VLDL production as a result of a lack of inhibition of hormone-sensitive lipase resulting in the production of small dense LDL. (38) Insulin resistance furthermore expedites cholesteryl ester transfer protein-mediate exchange of LDL cholesterol ester for VLDL triglycerides. This newly acquired LDL triglyceride undergoes lipolysis by hepatic and lipoprotein lipase, to form small dense LDL. (38, 39) It is therefore possible that the high prevalence of small dense LDL present in the CAD patients may, at least in part, be caused by the insulin resistance. From the results it is also clear that while non-smokers had an equal distribution of LDL particle size, smokers had a significantly higher prevalence of small dense LDL than large buoyant LDL. This suggests that smoking may contribute to the development of small dense LDL. Very little data is available regarding this in the literature and well controlled intervention studies are required to determine whether smoking can alter LDL size.
In contrast with the results of Nethononda et al., (11) should therefore be used in conjunction with food consumption patterns to determine the contribution of diet to CAD development in black Africans. Furthermore there was no difference in physical activity (moderately active) nor was there any differences in socio-demographic profile as both groups came from the same urban environment. One possible contributing factor that was not measured in this study may be mental stress. Differences in coping skills, for example, have been shown to increase inflammatory responses (40) and affect cardiometabolic risk, (41) despite all participants having a similar socio demographic background. It is also possible that the use of questionnaires to determine self reported dietary intakes and physical activity were not sensitive enough to distinguish between subtle differences that may contribute to the development of CAD.
In conclusion, black South African CAD patients had increased levels of the same risk factors that are typically seen in Caucasians with insulin resistance and small dense LDL being particularly significant in their contribution. Only modest differences were observed between patients and controls for other risk factors.
Apart from a lower vitamin C intake (possibly an indication of lower fruit and vegetable intake), no differences in dietary intakes and physical activity were observed between the CAD and control groups when matching for body fat, and both groups consumed more energy than required for a healthy body weight. It should be kept in mind that causality cannot be determined with a case control study design, and that generalisation of the study results should be done with caution due to the small sample size. Emerging data and our increasing understanding of the risk factor profile and pathophysiological processes involved in the increasing prevalence of CAD in black South Africans may have significant implications for the applicability of current public health dietary guidelines for the prevention of CAD in this group. Future research should be directed towards determining the cause of the insulin resistance and high prevalence of small dense LDL as possible strategies for preventing CAD in black South Africans.
